Heart Failure Drugs Flashcards
HFpEF leads to 4 things:
- Poor tolerance of Afib because no atrial contraction, this drops filling
- Poor tolerance of tachycardia because cannot fill
- Worsened by increased MAP
- “Flash” PE LIFETHREATENING and increases LA pressure
Eccentric hypertrophy is associated with
volume overload
Concentric hypertrophy is associated with
pressure overload
What is the general treatment option for treating heart failure?
- Remove and correct cause
- Prevent deterioration of cardiac function through drugs
- Control CHF state through diet, exercise, diuretics, vasodilators and digoxin
Less AII leads to:
- Less vasoconstriction leading to less afterload
- Less aldosterone secretion and less sodium/water retention to drop preload
- Less cell proliferation and remodeling
What are the two longer half life ACE inhibitors?
Benazepril and Lisinopril
Captopril is used to treat (3)
- HTN (add thiazide or loop diuretic if need more lowering)
- HFreEF
- Diabetic nephropathy
The the three adverse reactions of captopril:
- Angioedema
- Cough
- Fetal toxicity
What two drugs cause fetal toxicity?
Losartan and Captopril
Lose a Captain - losing a father
This ARB does not need activation
Valsartan - not a prodrug, excreted in feces as unchanged
This ARB has irreversible binding
Candesartan
Candy is irreversible
If ACEi don’t work for HF we use this drug
ARB
Patient has LV systolic failure. When would we want to avoid giving this drug?
Give ARB/ACEi UNLESS:
- Not tolerated (cough, angioedema)
- Pregnant (fetal toxicity)
- Hypotensive
- Serum creatinine > 3 mg/dL
- Hyperkalemia
This drug is used to reduce risk of CV death and hospitalization in patients with Class II-IV chronic heart failure with reduced EF
Valsartan/Sacubitril (which inhibits neprilysin)
Adverse effect: angioedema
This drug used for recent hx of MI or ACS and reduced EF, or HFrEF to prevent symptomatic HF
Carvedilol
Caveat: ONLY STABLE PATIENTS
MOA Carvedilol
Prevent downregulation of B1 adrenergic receptors to keep heart responsive to sympathetic stimulation during heart failure and drop renin secretion and limit remodeling
C is unique because it’s an inverse agonist
This drug should be given with ACEi to all patients with LV systolic dysfunction caused by MI to reduce mortality
B blockers
What is the warning of B blockers?
Don’t abruptly withdraw, gradually taper
When should we administer B blockers
LVEF < 40%, all patients with symptomatic CHF
What are your contraindications for B blockers?
Bronchospastic disease or heart block or bradycardia
If B blockers are contraindicated or are simply not working in HF, what do we give?
Ivabradine - This drug is given to patients with stable, symptomatic chronic heart failure with LVEF < 35%